仙鶴股份(603733.SH)近期醫療包裝用紙的生產不會對公司財務狀況產生重大影響
格隆匯2月4日丨仙鶴股份(603733.SH)公佈,公司股票於2020年2月3日、2月4日連續2個交易日內收盤價格漲幅偏離值累計達20%,根據《上海證券交易所交易規則》的有關規定,屬於股票交易異常波動情形。
近期,因武漢及全國各地發生新型冠狀病毒肺炎疫情,口罩等防護用品需求量顯著增加。公司生產的醫療包裝用紙,主要用於一次性醫療外科口罩、手術器械、防護服等醫療用品“無菌屏障系統”的包裝。醫用包裝用紙屬於食品與醫療包裝用紙分類系列產品,該類別為公司眾多產品品類之一,其中醫療包裝用紙2018年佔公司主營業務收入約為2%,比重較小。故近期醫療包裝用紙的生產不會對公司財務狀況產生重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.